Clinical trials
Recruiting Observational Head and Neck Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
97 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 10 |
| 2024 | 16 |
| 2025 | 22 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 97 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 4 |
| Nanfang Hospital, Southern Medical University | 4 |
| Royal Marsden NHS Foundation Trust | 4 |
| University Health Network, Toronto | 4 |
| European Institute of Oncology | 3 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3 |
| Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo | 2 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2 |
| Mayo Clinic | 2 |
| Samsung Medical Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 97 |
| Breast Neoplasms | 17 |
| Lung Neoplasms | 17 |
| Prostatic Neoplasms | 13 |
| Melanoma | 12 |
| Neoplasms | 12 |
| Colorectal Neoplasms | 9 |
| Kidney Neoplasms | 9 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Urinary Bladder Neoplasms | 9 |
Trials
Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.